Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

INKT vs ITWO: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ITWO Captures Overall Composite Edge (32.6 SELL vs 42.8 HOLD), While INKT Leads 3–0 on Growth & Valuation Pillars

ITWO Overall Winner 6-Pillar Tally: INKT 3 – 0 ITWO (3 Tie) Matrix Metrics: INKT 6 – 2 ITWO

As of Nov 20, 2026, ProShares Russell 2000 High Income ETF (ITWO) captures the overall head-to-head institutional edge over MiNK Therapeutics, Inc. (INKT) on higher Unified Composite conviction (32.6/100 SELL vs. 42.8/100 HOLD) after splitting the core matrix 2–6 (led by composite factor balance), while INKT wins 3–0 across the 6-pillar growth and valuation breakdown. INKT trades at $8.02 (N/M Forward P/E, -5720.7% operating margin) versus ITWO at $39.26 (N/M Forward P/E, N/A operating margin).

  • Composite vs. Pillar Nuance: While INKT currently prints a higher short-term Unified Composite Score (42.8/100 HOLD vs. ITWO 32.6/100 SELL), ITWO captures the overall institutional head-to-head verdict (2–6 matrix metrics and 0–3 across the 6 pillars) due to superior fundamental profitability (N/A vs. -5720.7% operating margin) and revenue trajectory (N/A vs. +0.0% YoY).
  • Technical & Structure Timing Caution: INKT is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 26.1); meanwhile ITWO is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 29.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About INKT vs ITWO
INKT NASDAQ
MiNK Therapeutics, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$8.02
-6.85% 1D
Market Cap $44.2M
TTM Revenue $200,000
Forward P/E N/M
Beta / 30D Vol 0.59β · 55% Vol
Unified Composite Score
42.8 / 100 HOLD
Tech 33.0 Fund 45.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -5.5%), weak momentum, RSI 26
RSI-14: 26.1 · SMA20: $9.98 · SMA50: $10.80
ITWO Cboe BZX Head-to-Head Winner
ProShares Russell 2000 High Income ETF
Institutional Equity
$39.26
-2.89% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 1.02β · 26% Vol
Unified Composite Score
32.6 / 100 SELL
Tech 10.0 Fund 43.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -3.0%), weak momentum, RSI 29
RSI-14: 29.0 · SMA20: $42.50 · SMA50: $42.90

6-Pillar Scorecard Institutional Category Breakdown (INKT 3 – 0 ITWO)

Columns: Metric · INKT · ITWO
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale INKT
Revenue Growth (YoY) +0.0% N/A
Earnings Growth (YoY) +0.0% N/A
TTM Revenue (USD) $200,000 N/A
Market Cap $44.2M N/A
3. Profitability & Quality INKT
Gross Margin 100.0% N/A
Operating Margin -5720.7% N/A
Net Profit Margin 0.0% N/A
Return on Equity (ROE) -1239.0% N/A
4. Balance Sheet & Cash Flow INKT
Cash Generation (TTM) -$6.3M N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage -1239.0% ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) 27.5% (50th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Biotechnology Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: INKT (6) vs ITWO (2)
Institutional Metric INKT ITWO Criterion Row Edge
Market Capitalization
Scale
$44.2M N/A Larger Scale INKT
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+0.0% N/A Higher Growth INKT
Operating Margin (TTM)
Profitability
-5720.7% N/A Higher Margin INKT
Net Profit Margin
Profitability
0.0% N/A Higher Margin INKT
Return on Equity (ROE)
Capital Efficiency
-1239.0% N/A Higher ROE INKT
52-Week Range Position
Momentum
3% ($8–$17) 22% ($37–$47) Stronger Trend ITWO
Beta / 30D Volatility
Risk Regime
0.59β · 55% Vol 1.02β · 26% Vol Lower Realized Risk ITWO
Unified Institutional Score
Composite Signal
42.8 / 100 (HOLD) 32.6 / 100 (SELL) Higher Composite INKT
Trailing 12M Revenue (USD)
Operating Scale
$200,000 N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
100.0% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$6.3M (-1239.0% ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ITWO +12.23 pp
INKT: -20.28% · ITWO: -8.05%
3M Horizon ITWO +17.35 pp
INKT: -32.15% · ITWO: -14.8%
6M Horizon ITWO +14.58 pp
INKT: -26.22% · ITWO: -11.64%
1Y Horizon ITWO +31.36 pp
INKT: -27.22% · ITWO: +4.14%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on INKT vs ITWO. Trailing 12-month operating profitability (INKT -5720.7% vs ITWO N/A) and valuation multiples (INKT N/M vs ITWO N/M Forward P/E) are benchmarked directly in Pillar 4 below.

INKT ADR TTM Benchmark FX-Normalized USD
TTM Revenue$200,000
Gross Margin100.0%
Op. Margin-5720.7%
ROE / Fwd P/E-1239.0% · N/M
ITWO ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
INKT UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact INKT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ITWO UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 27.5%
IV Percentile 50th %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ITWO Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
INKT Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $44.2M market capitalization and -5720.7% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
ITWO Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ INKT vs ITWO Key Questions & Quantitative Answers

As of Nov 20, 2026, ProShares Russell 2000 High Income ETF (ITWO) captures the overall head-to-head institutional edge over MiNK Therapeutics, Inc. (INKT) on higher Unified Composite conviction (32.6/100 SELL vs. 42.8/100 HOLD) after splitting the core matrix 2–6 (led by composite factor balance), while INKT wins 3–0 across the 6-pillar growth and valuation breakdown. INKT trades at $8.02 (N/M Forward P/E, -5720.7% operating margin) versus ITWO at $39.26 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While INKT currently prints a higher short-term Unified Composite Score (42.8/100 HOLD vs. ITWO 32.6/100 SELL), ITWO captures the overall institutional head-to-head verdict (2–6 matrix metrics and 0–3 across the 6 pillars) due to superior fundamental profitability (N/A vs. -5720.7% operating margin) and revenue trajectory (N/A vs. +0.0% YoY). Technical & Structure Timing Caution: INKT is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 26.1); meanwhile ITWO is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 29.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

INKT leads the Growth & Scale pillar: INKT posts +0.0% YoY revenue growth and +0.0% YoY earnings growth on $200,000 TTM revenue (100.0% gross margin, -5720.7% operating margin), compared with ITWO at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, INKT generates $200,000 in USD-normalized revenue versus N/A for ITWO. In operating R&D and SG&A reinvestment, INKT deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for ITWO.

INKT and ITWO trade at balanced relative valuation multiples. INKT trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin), whereas ITWO trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against INKT (-1239.0% ROE) versus ITWO (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, INKT carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.59β · 55% Vol realized risk). By comparison, ITWO carries 27.5% implied volatility (50th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.02β · 26% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.